Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05296746 |
|---|---|
| Brief Title: | Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer (RIBOLARIS) |
| First Submitted : | March 15, 2022 |
| First Submitted that Met QC Criteria : | March 24, 2022 |
| First Posted : | March 25, 2022 |
| Last Update Submitted that Met QC Criteria : | October 6, 2023 |
| Last Update Posted : | October 10, 2023 |